Clinical White Papers and Case Studies
-
Patient Diversity: Identifying Challenges, Opportunities, And Best Practices
4/10/2024
By listening to the voice of patient diversity and implementing FDA guidance measures, learn how stakeholders can improve trust, engagement, data reliability, patient outcomes, and promote public health.
-
Cystic Fibrosis: Global Clinical Trial Landscape (2024)
4/8/2024
Gain valuable insights on patient enrollment, site selection, and navigating global regulatory landscapes tailored to rare diseases, thus propelling forward CF research and treatment.
-
Acute Myeloid Leukaemia: Global Clinical Trial Landscape (2024)
4/8/2024
Learn how the collaboration among researchers, healthcare providers, and pharmaceutical industries holds promise for progress in Acute Myeloid Leukaemia management and care.
-
Patient Caregiver Network Improves Post-Seizure Trial Data
3/26/2024
Discover how a pharmaceutical CRO addressed concerns about seizure diary timing in a rare disease study, leveraging insights from Medable's Patient Community Network to optimize data collection.
-
Digital Biomarker Upholds Adherence, User Satisfaction, Validity
3/25/2024
Clinical outcome assessments can present challenges in clinical trials. Discover how this solution is able to utilize digital biomarkers to identify and measure clinically relevant signals in neurological conditions.
-
Digital Endpoint Resource Guide: Rheumatology
3/19/2024
Explore how wearables and sensor-based technologies provide continuous, remote patient-centered outcomes, reducing trial participation burdens, increasing success probabilities, and enhancing condition management.
-
Achieving Statistical Significance With Limited Patient Populations
3/15/2024
Explore highlights from a timely panel debate on emerging approaches to clinical research and data collection for advanced, novel and personalized therapies, especially linked to rare diseases.
-
Digital Endpoint Resource Guide: Neuromuscular Disorders
3/15/2024
Find out how sensor-based digital health technologies (DHTs) offer direct, objective daily life assessments, accelerating NMD drug development.
-
Rare Disease Prioritization Model And Landscape Analysis
3/15/2024
Uncover how a global pharmaceutical company seeking to identify promising indications among rare diseases to develop preclinical candidate molecules received an in-depth disease analysis to guide its strategic decision-making.
-
Bringing In Vitro Diagnostics To Market With Real-World Evidence
3/14/2024
Explore the potential of real-world evidence in enhancing the regulatory decision-making process to facilitate the market entry of IVDs.